Lipont Soy Isoflavone Complex
Natural health product licensed in Canada
- Other names
- Soy Isoflavone Complex, Women Menopausal Health, Women Soy Isoflavone
- Licence holder
- Libang Clinical Nutrition (Canada) Ltd.
- NPN or DIN-HM
- 80146916
- Status
- Active licence
- Licence date
- 16 January 2026
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 80 mg ÉAI Isoflavones | Not specified | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 30 mg ÉAI Genistein | 200 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Hypromellose, Dioxyde de silicium colloïdal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to attenuate/reduce/decrease bone (mineral density (BMD)) loss in postmenopausal women when used in conjunction with adequate amounts of calcium and vitamin D. May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80146916
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.